Evolus
EOLS
6.52
-0.48
-6.86%
Evolus
US · EOLS
#3736 by market cap
Listed 2018
6.52
-0.48
-6.86%
Periodic snapshot; not a real-time feed.
· 2026-11-20 19:30
Recent news
-
H.C. Wainwright Maintains Evolus(EOLS.US) With Buy Rating, Maintains Target Price $13Market Newswire · 2026/11/5
-
Analysts Offer Insights on Healthcare Companies: Evolus (EOLS), Parabilis Medicines, Inc. (PBLS) and Acumen Pharmaceuticals (ABOS)TipRanks · 2026/9/17
-
Rating change
Analysts Are Bullish on Top Healthcare Stocks: CG Oncology, Inc. (CGON), Evolus (EOLS)TipRanks · 2026/5/5
-
Rating change
Mizuho Securities Maintains Evolus(EOLS.US) With Buy Rating, Maintains Target Price $19Market Newswire · 2026/1/10
-
Rating change
Mizuho Securities Maintains Evolus(EOLS.US) With Buy Rating, Cuts Target Price to $15Market Newswire · 2026/2/4
-
A Quick Look at Today's Ratings for Evolus(EOLS.US), With a Forecast Between $13 to $20Market Newswire · 2026/11/6
-
BTIG Maintains Evolus(EOLS.US) With Buy Rating, Maintains Target Price $13Market Newswire · 2026/10/15
-
Company notice
Energy One Ltd: ENGIE in Australia selects EOLs EnergyOfferN/A · 2016/12/22
-
Mizuho Securities Maintains Evolus(EOLS.US) With Buy Rating, Maintains Target Price $15Market Newswire · 2026/9/11
-
Rating change
Analysts Are Bullish on These Healthcare Stocks: Evolus (EOLS), Upstream Bio, Inc. (UPB)TipRanks · 2026/2/4
-
Rating change
A Quick Look at Today's Ratings for Evolus(EOLS.US), With a Forecast Between $13 to $15Market Newswire · 2026/3/4
-
Rating change
BTIG Maintains Evolus(EOLS.US) With Buy Rating, Maintains Target Price $18Market Newswire · 2025/12/31
-
Rating change
Leerink Partners Maintains Evolus(EOLS.US) With Buy RatingMarket Newswire · 2026/9/17
-
Rating change
Needham Maintains Evolus(EOLS.US) With Hold RatingMarket Newswire · 2026/8/7
-
Company notice
Energy One Ltd: Leadership For EOL's Next EraASX · 2025/7/17
-
Rating change
Stifel Maintains Evolus(EOLS.US) With Buy Rating, Cuts Target Price to $17Market Newswire · 2026/1/13
-
Rating change
Stifel Maintains Evolus(EOLS.US) With Buy Rating, Maintains Target Price $17Market Newswire · 2026/8/6
-
Rating change
BTIG Maintains Evolus(EOLS.US) With Buy Rating, Cuts Target Price to $13Market Newswire · 2026/1/22
-
Rating change
A Quick Look at Today's Ratings for Evolus(EOLS.US), With a Forecast Between $13 to $17Market Newswire · 2026/8/6
-
Rating change
H.C. Wainwright Maintains Evolus(EOLS.US) With Buy Rating, Maintains Target Price $20Market Newswire · 2026/1/10
-
Rating change
Mizuho Securities Maintains Evolus(EOLS.US) With Buy Rating, Cuts Target Price to $19Market Newswire · 2025/12/2
-
H.C. Wainwright Maintains Evolus(EOLS.US) With Buy Rating, Maintains Target Price $13Market Newswire · 2026/8/25
-
Rating change
A Quick Look at Today's Ratings for Evolus(EOLS.US), With a Forecast Between $18 to $20Market Newswire · 2025/11/7
-
Rating change
Mizuho Securities Maintains Evolus(EOLS.US) With Buy Rating, Raises Target Price to $20Market Newswire · 2025/11/6
-
BTIG Maintains Evolus(EOLS.US) With Buy Rating, Maintains Target Price $13Market Newswire · 2026/8/7
Headlines are aggregated automatically and are not independently verified or edited by our team.
Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.
Evolus discussion 0 comments